HawkInsight

  • Contact Us
  • App
  • English

Outlook Therapeutics announces CEO resignation

Outlook Therapeutics (NASDAQ:OTLK) announced that Russell Trenary has stepped down as the president and chief executive officer, effective immediately.Lawrence Kenyon, executive vice president, chief financial officer and member of the board of directors, has been appointed interim CEO.OTLK shares were up 2.5% in after hours trading on Tuesday. Source: Press Release

Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.

NewFlashHawk Insight
More